检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

GEN3014 (HexaBody?-CD38) versus daratumumab in patients with relapsed/ refractory multiple myeloma: design of randomized head-to-head expansion cohort of phase 1/2 trial

Sebastian Grosicki,Binod Dhakal,Ehsan Malek,Maria Creignou,Wojciech Jurczak,Annemiek Broijl,Katrine Fladeland Iversen,Henrik Gregersen,Jakub Radocha,Jenny Chen, Adeleye Ogunkanmi,Andrew Spencer

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2023）

引用 0|浏览3
暂无评分
关键词
refractory multiple myeloma,daratumumab,head-to-head
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要